Zydus Lifesciences Limited Mesalamine Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Mesalamine Export Records India — #1 Exporter, 386 Shipments, $19.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mesalamine

India Pharmaceutical Trade Intelligence

$1.3B103 Suppliers51 CountriesHS 30049099

ExportsIndia → UNITED STATES98.6%India → RUSSIA0.4%

ImportsUNITED STATES → India$1.0M ISRAEL → India$27.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Zydus Lifesciences Limited — Mesalamine Exporter #1 | $19.3M Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Mesalamine Exporter Profile

Indian Pharmaceutical Exporter · #1 for Mesalamine · $19.3M export value · DGFT Verified

Zydus Lifesciences Limited is the #1 Indian exporter of Mesalamine with $19.3M in export value and 386 verified shipments. Zydus Lifesciences Limited holds a 1.5% market share in Mesalamine exports across 6 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Mesalamine Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Mesalamine export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Mesalamine?

Country	Value	Shipments	Share
UNITED STATES	$14.4M	349	91.8%
MEXICO	$763.4K	19	4.8%
BRAZIL	$235.8K	11	1.5%
SOUTH AFRICA	$100.0K	2	0.6%

Who Are the Top Buyers of Mesalamine from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$12.3M	280
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$1.9M	63
CEDIS CPA	MEXICO	$313.2K	9
ZYDUS NIKKHO FARMACEUTICA LTDA	BRAZIL	$235.8K	9
EVERSANA LIFE SCIENCE SERVICES,	UNITED STATES	$200.0K	4
ZYDUS PHARMACEUTICALS M?XICO S.A. D	MEXICO	$166.8K	4
ZYDUS PHARMACEUTICALS MXICO S.A.	MEXICO	$150.0K	3
ZYDUS HEALTHCARE SA (PTY) LTD	SOUTH AFRICA	$100.0K	2
ZYDUS PHARMACEUTICALS UK LTD	UNITED KINGDOM	$100.0K	2
EVERSANA LIFE SCIENCE SERVICES.	UNITED STATES	$88.5K	2

Zydus Lifesciences Limited supplies Mesalamine to 16 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) and CEDIS CPA (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Mesalamine Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
MESALAMINE DELAYED RELEASE TABLETS 1.2 GM	$2.9M	58
MESALAMINE DELAYED RELEASE TABLETS 1.2 G	$1.7M	34
MESALAMINE DELAYED RELEASE TABLETS 1.2 GMNOS	$750.0K	15
MESALAMINE DR TAB USP 800 MG 1 X 180	$550.0K	11
PHARMACEUTICAL MEDICINE FOR HUMAN USE -MESALAMINE DELAYED RELEASE TABLETS 1.2 GM- 1 X 120 - ECONO 1 X 120NOS	$450.0K	9
MESALAMINE RECTAL SUPPOSITORIES 1000MG (	$342.3K	15
MESALAMINE DELAYED RELEASE TABLETS 1 2 GM	$300.0K	6
PHARMACEUTICAL MEDICINE FOR HUMAN USE -MESALAMINE DELAYED RELEASE TABLETS 1.2 GM- 1 X 120 - ECONONOS	$300.0K	6
MESALAMINE DR TAB USP 800 MG 1 x 180	$250.0K	5
PHARMA : MESALAMINE DR TABLETS USP 800MG	$250.0K	5

Zydus Lifesciences Limited exports 136 distinct Mesalamine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MESALAMINE DELAYED RELEASE TABLETS 1.2 GM with 58 shipments worth $2.9M.

How Does Zydus Lifesciences Limited Compare to Nearest Mesalamine Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ZYDUS LIFESCIENCES LIMITED ★	$19.3M	386	6	$50.0K
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$10.3M	207	11	$50.0K
4	ANNORA PHARMA PRIVATE LIMITED	$7.8M	157	1	$50.0K

Zydus Lifesciences Limited ranks #1 among 103 Indian Mesalamine exporters. Average shipment value of $50.0K compared to the market average of $469.7K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and ANNORA PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Mesalamine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	801	21.2%
SAHAR AIR	789	20.9%
DELHI AIR	494	13.1%
SAHAR AIR CARGO ACC (INBOM4)	415	11.0%
MUNDRA SEA	134	3.5%
Delhi Air	131	3.5%
Bombay Air	120	3.2%
NHAVA SHEVA SEA (INNSA1)	70	1.9%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Mesalamine Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mesalamine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 386 individual customs records matching Zydus Lifesciences Limited exporting Mesalamine, covering 136 formulations to 7 countries via 16 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 51+ countries, 214+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mesalamine

Mesalamine

Zydus Lifesciences Limited — Mesalamine Exporter Profile

Zydus Lifesciences Limited — Mesalamine Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Mesalamine?

Who Are the Top Buyers of Mesalamine from Zydus Lifesciences Limited?

What Is India's Total Mesalamine Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Mesalamine Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Mesalamine Exporters?

What Mesalamine Formulations Does Zydus Lifesciences Limited Export?

Regulatory Requirements: Exporting Mesalamine to Key Markets

United States — FDA

Mexico — COFEPRIS

Brazil — ANVISA

How Does Zydus Lifesciences Limited Compare to Nearest Mesalamine Exporters?

Which Indian Ports Ship Mesalamine Exports?

What Other Gastrointestinal Products Does Zydus Lifesciences Limited Export?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Mesalamine Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mesalamine Export Data from Zydus Lifesciences Limited

Mesalamine Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source